AI Insight
A clinical trial investigated whether altering gut microbiomes could reduce peanut allergy severity in adults. Six individuals with peanut allergy received faecal microbiota transplants from donors without allergies. The treatment resulted in improved peanut tolerance among the participants, suggesting that gut bacteria composition may play a role in food allergies.
Why it matters
This approach could offer a novel treatment pathway for food allergies, which currently have limited therapeutic options beyond avoidance and emergency medication. If validated in larger studies, microbiome-based interventions might provide long-term relief for millions of people living with potentially life-threatening food allergies.
Understand the Science
Altering the gut microbiomes of people with peanut allergy using faeces donated from an allergy-free individual improved their peanut tolerance in a clinical trial
Source: Swallowing faecal capsules reduces peanut allergy in six adults